Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| CAC | PRESS-RELEASE | neutral | 4/10 | 🔒Camden National reported Q3 2026 net income of $22.8M and diluted EPS of $1.34, up 8% and 7% YoY respectively, matching | Oct 27, 2026 |
| BFH | PRESS-RELEASE | bearish | 5/10 | 🔒Bread Financial launched an underwritten public offering of depositary shares representing a 1/40th interest in its Seri | Oct 27, 2026 |
| SXTP | PRESS-RELEASE | bullish | 6/10 | 🔒60 Degrees Pharmaceuticals reported positive clinical and molecular results from the first five patients to complete tre | Oct 27, 2026 |
| SAIQ | PRESS-RELEASE | neutral | 3/10 | 🔒WISeSat.Space announced an expanded strategic collaboration with Kaynes Space Technology to develop post-quantum securit | Oct 27, 2026 |
| ACLS | PRESS-RELEASE | neutral | 2/10 | 🔒Axcelis Technologies appointed Jeroen Delsman as EVP and CFO effective November 12, 2026, replacing interim CFO David Ry | Oct 27, 2026 |
| EEFT | PRESS-RELEASE | bearish | 6/10 | 🔒Euronet reported Q3 2026 adjusted EPS of $3.55, missing the $3.69 consensus by 3.8%, and revenue of $1.161B, below the $ | Oct 27, 2026 |
| ACTU | PRESS-RELEASE | bearish | 6/10 | 🔒Actuate Therapeutics priced an underwritten public offering of 30,985,900 shares and warrants at $0.71 per set, expectin | Oct 27, 2026 |
| TEVA | PRESS-RELEASE | neutral | 5/10 | 🔒Teva completed the acquisition of BioXcel Therapeutics' neuroscience assets, including worldwide rights to BXCL501 (an i | Oct 27, 2026 |
| CBC | PRESS-RELEASE | neutral | 4/10 | 🔒Central Bancompany reported Q3 2026 GAAP EPS of $0.48, missing the $0.49 consensus by 2.0%, while adjusted revenue of $2 | Oct 27, 2026 |
| CTS | PRESS-RELEASE | bullish | 6/10 | 🔒CTS reported Q3 2026 adjusted diluted EPS of $0.77, beating the $0.65 consensus, and revenue of $149.6M, up 5% YoY and a | Oct 27, 2026 |
| AUBN | PRESS-RELEASE | neutral | 4/10 | 🔒Auburn National Bancorporation reported Q3 2026 EPS of $0.72, up 13% from $0.64 in Q3 2025, driven by net interest margi | Oct 27, 2026 |
| ITW | PRESS-RELEASE | neutral | 5/10 | 🔒ITW reported Q3 2026 GAAP EPS of $3.00, beating the $2.97 consensus by 1.0%, and revenue of $4.24B, slightly below the $ | Oct 27, 2026 |
| MLCI | PRESS-RELEASE | neutral | 3/10 | 🔒BC Partners, a founding shareholder and strategic partner of Mount Logan Capital, announced a plan to purchase up to $1. | Oct 27, 2026 |
| CAMP | PRESS-RELEASE | bullish | 6/10 | 🔒CAMP4 Therapeutics received CTA approval from multiple EU countries to initiate its global Phase 1/2 ASCEND trial of CMP | Oct 27, 2026 |
| MASK | PRESS-RELEASE | neutral | 3/10 | 🔒3E Network Technology Group detailed the use of proceeds from its $5.0 million private placement, allocating funds to AI | Oct 27, 2026 |
| OPRX | PRESS-RELEASE | neutral | 3/10 | 🔒OptimizeRx announced a partnership with PulsePoint to make its authenticated EHR and e-prescribing inventory available t | Oct 27, 2026 |
| WSO | PRESS-RELEASE | bearish | 5/10 | 🔒Watsco reported record Q3 2026 revenue of $2.22 billion (+7% YoY), but EPS fell 5% to $3.77, missing the $4.09 consensus | Oct 27, 2026 |
| HUBB | PRESS-RELEASE | bullish | 6/10 | 🔒Hubbell reported Q3 2026 adjusted diluted EPS of $5.91, up 14% YoY and above the $5.75 consensus estimate, on net sales | Oct 27, 2026 |
| NWFL | PRESS-RELEASE | bullish | 6/10 | 🔒Norwood Financial Corp (NWFL) reported Q3 2026 diluted EPS of $1.08, beating the $0.94 consensus by 14.9%, and revenue o | Oct 27, 2026 |
| KNSA | PRESS-RELEASE | bullish | 6/10 | 🔒Kiniksa reported Q3 2026 ARCALYST net product revenue of $286.0M, up ~58% YoY, and raised full-year 2026 ARCALYST revenu | Oct 27, 2026 |
| WVE | PRESS-RELEASE | neutral | 5/10 | 🔒Wave Life Sciences reported Q3 2026 revenue of $13.2M (up from $7.6M a year ago) and a net loss of $61.9M ($0.30 per sha | Oct 27, 2026 |
| SPGI | PRESS-RELEASE | bullish | 6/10 | 🔒S&P Global reported Q3 2026 revenue of $3.678B (+7% YoY) and GAAP diluted EPS of $4.45 (+26% YoY), both above consensus. | Oct 27, 2026 |
| CLRB | PRESS-RELEASE | bullish | 6/10 | 🔒Cellectar Biosciences reported a case study showing a durable complete response lasting over eight years in a heavily pr | Oct 27, 2026 |
| GLXY | PRESS-RELEASE | bullish | 6/10 | 🔒Galaxy Digital reported Q3 2026 net income of $323M and adjusted EPS of $0.83, well above the $0.20 consensus. Revenue a | Oct 27, 2026 |
| GXO | PRESS-RELEASE | neutral | 3/10 | 🔒GXO Logistics announced the opening of a new strategic logistics hub in Medini, Malaysia, within the Johor-Singapore Spe | Oct 27, 2026 |
| FTRE | PRESS-RELEASE | neutral | 2/10 | 🔒Fortrea announced that its CEO, CFO, and SVP of Investor Relations will participate in an upcoming conference. The press | Oct 27, 2026 |
| RGEN | PRESS-RELEASE | bullish | 6/10 | 🔒Repligen reported Q3 2026 adjusted EPS of $0.53, beating the $0.46 consensus by 15.2%, and revenue of $209.3M, above the | Oct 27, 2026 |
| SMPL | PRESS-RELEASE | bearish | 5/10 | 🔒Simply Good Foods reported Q4 2026 adjusted EPS of $0.44, beating the $0.40 consensus, but net sales of $333.3M missed t | Oct 27, 2026 |
| PYPL | PRESS-RELEASE | bullish | 6/10 | 🔒PayPal reported Q3 2026 EPS of $1.42, beating the $1.31 consensus by 8.4%, and revenue of $8.83B, above the $8.71B estim | Oct 27, 2026 |
| SHW | PRESS-RELEASE | neutral | 5/10 | 🔒Sherwin-Williams reported Q3 2026 adjusted EPS of $3.63, slightly below the $3.69 consensus, while revenue of $6.86B bea | Oct 27, 2026 |